N
CBIO

Nuveen’s Crescent Biopharma CBIO Stock Holding History

Nuveen’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,591
Closed -$3.19M – 3439
2021
Q1 		$3.19M Buy
10,591
+6,685
+171% +$2.39M ﹤0.01% 2391
2020
Q4 		$1.47M Buy
3,906
+483
+14% +$169K ﹤0.01% 2659
2020
Q3 		$1.05M Buy
3,423
+1,896
+124% +$725K ﹤0.01% 2666
2020
Q2 		$575K Buy
1,527
+200
+15% +$56.6K ﹤0.01% 2845
2020
Q1 		$302K Sell
1,327
-13
-1% -$4.97K ﹤0.01% 2926
2019
Q4 		$709K Hold
1,340
– – ﹤0.01% 2807
2019
Q3 		$577K Sell
1,340
-78
-6% -$50.2K ﹤0.01% 2894
2019
Q2 		$1.69M Buy
+1,418
New +$1.7M ﹤0.01% 2511

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return